Sowell Financial Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-828
Closed -$160K 2248
2021
Q1
$160K Buy
828
+418
+102% +$83.8K 0.01% 1163
2020
Q4
$87K Buy
410
+358
+688% +$71.4K ﹤0.01% 1207
2020
Q3
$9K Sell
52
-4
-7% -$739 ﹤0.01% 1841
2020
Q2
$11K Buy
56
+24
+75% +$3.93K ﹤0.01% 1668
2020
Q1
$5K Sell
32
-1,468
-98% -$234K ﹤0.01% 1832
2019
Q4
$232K Buy
1,500
+1,446
+2,678% +$208K 0.02% 664
2019
Q3
$7K Buy
+54
New +$7.08K ﹤0.01% 1649

Other funds holding RMD

Sowell Financial Services's RMD Position: Q2 2021 in Review

Sowell Financial Services sold out of ResMed (RMD) in Q2 2021, closing a stake of 828 shares — an estimated $160K sold.

Sowell Financial Services first reported a position in RMD in Q3 2019 and held it in 7 quarters. The position peaked at $232K in Q4 2019. 662 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Sowell Financial Services reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 828 ResMed shares in Q2 2021, an estimated $160K.
  • Sowell Financial Services first reported a position in ResMed in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's ResMed position peaked at $232K in Q4 2019.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.